Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915831 · ClinicalTrials.gov registry record · NA
Type 1 Diabetes and Obstructive Sleep Apnea
A NA study of Sleep Apnea, Obstructive and Type 1 Diabetes (T1D), sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06915831: Recruiting NA study of Sleep Apnea, Obstructive and Type 1 Diabetes (T1D), sponsored by University of Chicago.
NCT06915831 is a NA study of Sleep Apnea, Obstructive and Type 1 Diabetes (T1D) that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 40 participants, below the 261-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06915831, a NA study of Sleep Apnea, Obstructive and Type 1 Diabetes (T1D), is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.
Primary Outcome
Glycemic variability will be calculated using a standard metric as percent coefficient of variation (% CV) of glucose values obtained from continuous glucose monitoring (CGM).
Conditions Studied
Interventions
- DEVICE Continuous positive airway pressure (CPAP)
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-11-10 |
| Est. Completion | 2029-08-31 |
| Phase | NA |
What NCT06915831 shows while recruiting
NCT06915831 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 261-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 1 intervention - of which Continuous positive airway pressure (CPAP) is the first listed.
NCT06915831 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06915831 about?
NCT06915831 is a clinical study titled "Type 1 Diabetes and Obstructive Sleep Apnea". The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.
What is the current status of trial NCT06915831?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-11-10. Estimated completion is 2029-08-31.
What conditions does trial NCT06915831 study?
This clinical trial studies the following conditions: Sleep Apnea, Obstructive, Type 1 Diabetes (T1D).
What interventions are being tested in trial NCT06915831?
The interventions under investigation include: Continuous positive airway pressure (CPAP) (DEVICE).
Who is sponsoring clinical trial NCT06915831?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06915831 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea, Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06915831's enrollment target sits among peer trials
40 29th of 45 higher than 15 of 45 other Sleep Apnea, Obstructive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Apnea, Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
RECRUITING · NA
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
-
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
RECRUITING · NA
-
The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention
RECRUITING · NA
-
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients
RECRUITING · NA
-
Long-term Evaluation of a Nasopharyngeal Airway
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI